You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daratumumab (JNJ-54767414)

Showing 51 - 75 of 632
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patient and Healthcare Provider Satisfaction of Daratumumab Use

Recruiting
  • Multiple Myeloma
  • +5 more
  • Daratumumab
  • Frankfurt, Hessen, Germany
    Centrum für Hämatologie und Onkologie Bethanien
Aug 1, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Smoldering Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Daratumumab)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Tampa, Florida
  • +9 more
Jul 8, 2022

Alzheimer Trial in Manhasset (Daratumumab Injection)

Recruiting
  • Alzheimer Disease
  • Daratumumab Injection
  • Manhasset, New York
    The Litwin-Zucker Research Center
Nov 16, 2021

Lymphoma Trial in Worldwide (Daratumumab)

Completed
Has Results
  • Lymphoma
  • Beijing, China
  • +16 more
Dec 18, 2020

Multiple Myeloma Trial in United States (Daratumumab, Cyclophosphamide, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • Mobile, Alabama
  • +25 more
Oct 7, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, velcade, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +12 more
Aug 25, 2021

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Jan 9, 2023

Light Chain (AL) Amyloidosis, Stage 3B Trial in Worldwide (Daratumumab, Bortezomib Injection, Dexamethasone oral tablet)

Recruiting
  • Light Chain (AL) Amyloidosis, Stage 3B
  • Créteil, France
  • +4 more
Sep 29, 2021

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma Trial in United States (drug,

Recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Anchorage, Alaska
  • +459 more
Dec 7, 2022

Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

Not yet recruiting
  • Advanced Prostate Cancer
  • Lyon, France
  • +2 more
Oct 18, 2023

Autoimmune Disorders Trial in United States (Daratumumab)

Not yet recruiting
  • Autoimmune Disorders
  • Daratumumab
  • Baltimore, Maryland
  • +7 more
Jan 4, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)

Recruiting
  • Multiple Myeloma
  • TTI-622
  • Daratumumab Hyaluronidase-fihj
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +117 more
Aug 3, 2022

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Dec 28, 2022

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

Plasma Cell Leukemia Trial in United States (Bortezomib, Daratumumab, Dexamethasone)

Withdrawn
  • Plasma Cell Leukemia
  • Duarte, California
  • +4 more
Dec 17, 2018

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Nov 15, 2023

Healthy Trial in Lincoln (JNJ-68179280, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jan 17, 2023

Multiple Myeloma Trial in Irvine (89Zr-daratumumab PET/CT)

Recruiting
  • Multiple Myeloma
  • 89Zr-daratumumab PET/CT
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
Aug 1, 2022